Expression of PD-1/PD-L1 axis in mediastinal lymph nodes and lung tissue of human and experimental lung fibrosis indicates a potential therapeutic target for idiopathic pulmonary fibrosis

被引:0
作者
Theodoros Karampitsakos
Apostolos Galaris
Serafeim Chrysikos
Ourania Papaioannou
Ioannis Vamvakaris
Ilianna Barbayianni
Paraskevi Kanellopoulou
Sofia Grammenoudi
Nektarios Anagnostopoulos
Grigoris Stratakos
Matthaios Katsaras
Fotios Sampsonas
Katerina Dimakou
Effrosyni D. Manali
Spyridon Papiris
Bochra Tourki
Brenda M Juan-Guardela
Petros Bakakos
Demosthenes Bouros
Jose D Herazo-Maya
Vassilis Aidinis
Argyris Tzouvelekis
机构
[1] University Hospital of Patras,Department of Respiratory Medicine
[2] University of South Florida,Ubben Center and Laboratory for Pulmonary Fibrosis Research, Morsani College of Medicine
[3] Institute of Bio- Innovation,5th Department of Pneumonology
[4] Biomedical Sciences Research Center Alexander Fleming,Department of Pathology
[5] Hospital for Thoracic Diseases,First Academic Department of Pneumonology, “SOTIRIA”, Medical School
[6] “SOTIRIA”,2nd Pulmonary Medicine Department, Athens Medical School
[7] Hospital for Thoracic Diseases,undefined
[8] “SOTIRIA”,undefined
[9] Hospital for Thoracic Diseases,undefined
[10] National and Kapodistrian University of Athens,undefined
[11] “ATTIKON” University Hospital,undefined
[12] National and Kapodistrian University of Athens,undefined
来源
Respiratory Research | / 24卷
关键词
Idiopathic pulmonary fibrosis; Mediastinal lymph nodes; Lung cancer; PD-1/PD-L1 axis; Pembrolizumab;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Clinical Significance of PD-L1 Status and the Expression of PD-1 in Tumor-Infiltrating Lymphocytes (TILs) in Lung Cancer
    Ortiz-Villalon, Cristian
    Karagkounis, Georgios
    Kis, Lorand
    Lewensohn, Rolf
    Rassidakis, Georgios
    Tendler, Salomon
    De Petris, Luigi
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1514 - S1514
  • [22] Changes in expression of PD-L1 on peripheral T cells in patients with melanoma and lung cancer treated with PD-1 inhibitors
    Dart, Sarah J.
    Cook, Alistair M.
    Millward, Michael J.
    McDonnell, Alison M.
    Chin, Wee L.
    Hakeem, Muhammad U.
    Meniawy, Tarek M.
    Bowyer, Samantha E.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [23] Companion and Complementary Diagnostics-Focus on PD-L1 Expression Assays for PD-1/PD-L1 Checkpoint Inhibitors in Non-Small Cell Lung Cancer
    Hersom, Maria
    Jorgensen, Jan T.
    [J]. THERAPEUTIC DRUG MONITORING, 2018, 40 (01) : 9 - 16
  • [24] A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue
    Shanmugasundaram, Karthik B.
    Ahmed, Emtiaz
    Miao, Xinzhe
    Kulasinghe, Arutha
    Fletcher, James A.
    Monkman, James
    Mainwaring, Paul
    Masud, Mostafa Kamal
    Park, Hyeongyu
    Hossain, Md Shahriar A.
    Yamauchi, Yusuke
    Sina, Abu A. I.
    O'Byrne, Kenneth
    Wuethrich, Alain
    Trau, Matt
    [J]. ACS SENSORS, 2024, 9 (06): : 3009 - 3016
  • [25] Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer
    Calles, Antonio
    Liao, Xiaoyun
    Sholl, Lynette M.
    Rodig, Scott J.
    Freeman, Gordon J.
    Butaney, Mohit
    Lydon, Christine
    Dahlberg, Suzanne E.
    Hodi, F. Stephen
    Oxnard, Geoffrey R.
    Jackman, David M.
    Jaenne, Pasi A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (12) : 1726 - 1735
  • [26] PD-1/PD-L1 Inhibitors as Monotherapy in the First-Line Treatment of Advanced Non-Small Cell Lung Cancer Patients with High PD-L1 Expression: An Expert Position Statement
    Isla, Dolores
    Sanchez, Alfredo
    Casal, Joaquin
    Cobo, Manuel
    Majem, Margarita
    Reguart, Noemi
    Zugazagoitia, Jon
    Bernabe, Reyes
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (15)
  • [27] PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis
    Li, Jing
    Gu, Jian
    [J]. FUTURE ONCOLOGY, 2019, 15 (14) : 1667 - 1678
  • [28] PD-1/PD-L1 inhibitors in treatment-naive, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials
    Wankhede, Durgesh
    Hofman, Paul
    Grover, Sandeep
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (05) : 2179 - 2189
  • [29] Current Clinical Progress of PD-1/PD-L1 Immunotherapy and Potential Combination Treatment in Non-Small Cell Lung Cancer
    Li, Jia-Xin
    Huang, Ju-Min
    Jiang, Ze-Bo
    Li, Run-Ze
    Sun, Ao
    Leung, Elaine Lai-Han
    Yan, Pei-Yu
    [J]. INTEGRATIVE CANCER THERAPIES, 2019, 18
  • [30] Expression of PD-1/PD-L1 and PD-L2 in peripheral T-cells from non-small cell lung cancer patients
    Arrieta, Oscar
    Montes-Servin, Edgar
    Hernandez-Martinez, Juan-Manuel
    Cardona, Andres F.
    Casas-Ruiz, Eibar
    Crispin, Jose C.
    Motola, Daniel
    Flores-Estrada, Diana
    Barrera, Lourdes
    [J]. ONCOTARGET, 2017, 8 (60) : 101994 - 102005